Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-013704-31Phase 4Completed
Phase 4, open-label, single-arm trial of rifampicin, sponsored by Oulu University Hospital. Primary endpoints: Change in HOMA-IR index, Change in fasting glucose and 1 more. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-013704-31.